Literature DB >> 35203840

Pathogens and Antibiotic Susceptibilities of Global Bacterial Keratitis: A Meta-Analysis.

Zijun Zhang1, Kai Cao1, Jiamin Liu1, Zhenyu Wei1, Xizhan Xu1, Qingfeng Liang1.   

Abstract

Bacterial keratitis (BK) is the most common type of infectious keratitis. The spectrum of pathogenic bacteria and their susceptibility to antibiotics varied with the different regions. A meta-analysis was conducted to review the global culture rate, distribution, current trends, and drug susceptibility of isolates from BK over the past 20 years (2000-2020). Four databases were searched, and published date was limited between 2000 and 2020. Main key words were "bacterial keratitis", "culture results" and "drug resistance". Forty-two studies from twenty-one countries (35 cities) were included for meta-analysis. The overall positive culture rate was 47% (95%CI, 42-52%). Gram-positive cocci were the major type of bacteria (62%), followed by Gram-negative bacilli (30%), Gram-positive bacilli (5%), and Gram-negative cocci (5%). Staphylococcus spp. (41.4%), Pseudomonas spp. (17.0%), Streptococcus spp. (13.1%), Corynebacterium spp. (6.6%) and Moraxella spp. (4.1%) were the most common bacterial organism. The antibiotic resistance pattern analysis revealed that most Gram-positive cocci were susceptive to aminoglycoside (86%), followed by fluoroquinolone (81%) and cephalosporin (79%). Gram-negative bacilli were most sensitive to cephalosporin (96%) and fluoroquinolones (96%), followed by aminoglycoside (92%). In Gram-positive cocci, the susceptibility trends of fluoroquinolones were decreasing since 2010. Clinics should pay attention to the changing trends of pathogen distribution and their drug resistance pattern and should diagnose and choose sensitive antibiotics based on local data.

Entities:  

Keywords:  antibiotic; bacteria; keratitis; microorganisms; susceptibility

Year:  2022        PMID: 35203840      PMCID: PMC8868051          DOI: 10.3390/antibiotics11020238

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


1. Introduction

Infectious keratitis (IK) is a potentially sight-threatening condition, which leads to at least 1.5 to 2 million new cases of unilateral blindness every year [1,2,3]. Among them, bacterial keratitis (BK) is the most common type according to the reports from multiple regions such as UK [4,5,6,7], North & South America [8,9,10,11], Middle East [12] and Australia [13,14]. Common risk factors for BK were contact lens wear, ocular trauma, ocular surface disease, and prior ocular surgery [15]. Bacterial culture via corneal scraping samples is still the gold standard for the diagnosis of BK, which permits isolation of the causal bacteria. However, not all medical institutions are able to carry out those tests due to various limitations. Therefore, it is critical for clinicians to make empirical diagnosis to know the pathogenic microorganism and antibiotics appropriate for eradicating the infection [16]. The common organisms that cause bacterial keratitis include Staphylococcus aureus, Coagulase-negative staphylococci (CoNS), Streptococcus pneumoniae, and others [17,18,19,20,21]. The bacterial spectrum and drug susceptibility for bacterial isolates from different areas or periods are widely reported [5,8,18,22,23], but the most common pathogen of BK remains debatable. Pseudomonas spp. were demonstrated to be the most common pathogen in Malaysia [22], Iran [23] and Taiwan [16], while CoNS are reported to be the most common in UK [5,6,24] and Australia [13]. Due to the widespread use of broad-spectrum antibiotics, it is very likely that the bacterial spectrum and its resistance to antibiotics varies greatly over time and from area to area. However, a comprehensive worldwide and long-term data analysis is scarce. To analyze the trends of bacteria and drug resistance profile over time in the world, we conducted a meta-analysis to compare the positive rate of culture in medical facilities worldwide and summarize the temporal and spatial trends of microbial isolates and their susceptibility patterns since 2000.

2. Results

2.1. Literature Search and Study Characteristics

From the selected databases, 4734 potentially relevant references were identified. In total, 1156 references were excluded because of duplicates. Details of searching and de-duplications were shown in Appendix A. Search results were shown in Appendix B by reviewing the titles and abstracts, and 3459 references were excluded. After reading 119 full texts, 16 articles were excluded, and 103 papers were assessed for eligibility. A total of 42 studies were ultimately included in this meta-analysis, of which only 38 articles contained enough information for positive rate analysis, and 33 articles for drug susceptibility analysis. We used the methodological scoring system of “rate” to assess the quality of each study. The score of all studies were more than 4 points. The paper selection process was shown in Figure 1, and the characteristics of the included studies were shown in Table 1. We used the methodological scoring system of “rate” to assess the quality of each study. The score of all studies were more than 4 points. The paper selection process was shown in Figure 1, and the characteristics of the included studies was shown in Table 1. Among these data, 16 articles were reported from Asia, 11 from America, 1 from Africa, 9 from Europe and 5 from Oceania.
Figure 1

The PRISMA flow chart of paper selection.

Table 1

Characteristics of the studies included in the meta-analysis.

Authors (Years)CountryCityStudy PeriodSample SizePositive Rate (%)Microbiological Profiles
Europe
Schaefer (2001)SwitzerlandLausanne1997–19988586Staphylococcus epidermidis (29.0%)Staphylococcus aureus (16.0%)Pseudomonas species (7.0%)
Saeed (2009)IrelandDublin2001–20039036Pseudomonas species (33.3%)Coagulase negative staphylococci (12.1%)Staphylococcus aureus (9.0%)
Orlans (2011)UKOxford1999–200946754Coagulase negative staphylococci (25.8%)Pseudomonas aeruginosa (24.3%)Staphylococcus aureus (14.3%)
Prokosch (2012)GermanyMünster2002–200934643Staphylococcus aureus (31.7%)Pseudomonas species (7.5%)Streptococcus pneumoniae (6.0%)
Otri (2013)UKNottingham2007–200712935Staphylococcus aureus (18.8%)Pseudomonas aeruginosa (15.0%)Pneumococcus (9.4%)
Tan (2017)UKManchester2004–2015422930Coagulase negative staphylococci (38.5%)Pseudomonas (37.1%)Staphylococcus aureus (23.9%)
Ferreira (2018)PortugalPorto2007–201523538Staphylococcus aureus (23.1%)Corynebacterium macginleyi (20.0%)Pseudomonas aeruginosa (13.8%)
Tavassoli (2019)UKBristol2006–2017211638Coagulase negative staphylococci (49.9%)Pseudomonas species (22.0%)Streptococci (9.7%)
Tena (2019)SpainGuadalajara2010–201629865Coagulase negative staphylococci (28.6%)Cutibacterium species (19.6%)Corynebacterium species (9.8%)
Africa
Capriotti (2010)Sierra LeoneFreetown2005–20067358Pseudomonas aeruginosa (39.7%)Staphylococcus aureus (27.4%)Coagulase negative staphylococci (5.5%)
Asia
Sharma (2007)IndiaHyderabad2002–200217062Staphylococcus epidermidis (18.6%)Streptococcus pneumoniae (18.6%)Pseudomonas species (4.9%)
Yilmaz (2007)TurkeyIzmir1990–200562028Staphylococcus epidermidis (26.6%)Staphylococcus aureus (24.4%)Streptococcus pneumoniae (15.5%)
Fong (2007)ChinaTaipei1994–2005272-Pseudomonas aeruginosa (46.7%)Cutibacterium species (8.1%)Nontuberculous Mycobacteria (6.6%)
Lavaju (2009)NepalDharan2007–20084436Staphylococcus aureus (70.0%)Pseudomonas species (15.0%)Acinetobactor species (5.0%)
Feilmeier (2010)NepalKathmandu2006–200946815Streptococcus pneumoniae (69.0%)Staphylococcus aureus (11.0%)Staphylococcus epidermidis (7.0%)
Dhakhwa (2012)NepalSiddharthanagar200741439Staphylococcus epidermidis (29.6%)Streptococcus viridans (15.1%)Pseudomonas aeruginosa (14.0%)
Lin (2012)IndiaMadurai2006–2009522121Staphylococcus epidermidis (31.9%)Pseudomonas aeruginosa (12.4%)Staphylococcus simulans (5.5%)
Politis (2016)IsraelJerusalem2002–201494344Coagulase-negative staphylococci (43.9%)Pseudomonas aeruginosa (24.8%)Streptococcus pneumoniae (6.9%)
Hsiao (2016)ChinaTaoyuan2003–2012201240Pseudomonas aeruginosa (24.4%)Coagulase-negative staphylococci (16.6%)Cutibacterium species (9.1%)
Aruljyothi (2016)IndiaMadurai2011–201323430Pseudomonas aeruginosa (37.9%)Streptococcus pneumoniae (24.1%)Staphylococcus aureus (12.0%)
Lin (2017)ChinaGuangzhou2009–2013297312Staphylococcus epidermidis (31.9%)Pseudomonas aeruginosa (12.4%)Staphylococcus simulans (5.5%)
Bagga (2018)IndiaHyderabad1991–20126042Staphylocci (35.0%)Corynebacteria (25.5%)Streptococci (24.0%)
Mun (2019)KoreaSeoul2007–201612978Coagulase negative staphylococci (15.9%)Staphylococcus aureus (12.1%)Pseudomonas aeruginosa (10.3%)
Liu (2019)ChinaTaipei2007–201636351Pseudomonas species (44.7%)Nontuberculous Mycobacteria (7.5%)Propioebacterium species (6.8%)
Das (2019)IndiaHyderabad2007–2014398129Streptococcus pneumoniae (16.1%)Staphylococcus aureus (13.8%)Pseudomonas species (7.4%)
Khor (2020)MalaysiaSarawak2010–201622130Pseudomonas aeruginosa (33.6%)Staphylococcus aureus (3.4%)Corynebacterium species (1.7%)
Oceania
Hall (2004)New ZealandChristchurch1997–20018759Coagulase negative staphylococci (19.3%)Moraxella species (19.3%)Coryebacterium species (16.0%)
Ly (2006)AustraliaSydney2002–200311242Coagulase negative staphylococci (38.0%)Pseudomonas aeruginosa (21.0%)Corynebacterium species and coryneform bacteria (15.0%)
Constantinou (2009)AustraliaMelbourne1998–20074770Pseudomonas aeruginosa (33.3%)Coagulase negative staphylococci (11.1%)Cutibacterium acnes (8.9%)
Pandita (2011)New ZealandHamilton200726565Coagulase negative staphylococci (40.8%)Staphylococcus aureus (11.5%)Streptococcus pneumonia (7.5%)
Watson (2019)AustraliaSydney201622475Coagulase negative staphylococci (47.8%)Staphylococcus aureus (9.6%)Pseudomonas aeruginosa (9.6%)
America
Alexandrakis (2000)USAMiami1990–1998292050Pseudomonas aeruginosa (25.7%)Staphylococcus aureus (19.4%)Serratia marcescens (7.6%)
Yeh (2006)USADurham1997–200445368Coagulase negative staphylococci (39.0%)Staphylococcus aureus (12.0%)Pseudomonas species (10.0%)
Afshari (2008)USABoston1999–200048566Coagulase negative staphylococci (45.5%)Staphylococcus aureus (15.2%)Diphtheroids (5.7%)
Lichtinger (2012)CanadaToronto2000–2010170153Coagulase negative staphylococci (37.0%)Staphylococcus aureus (17.0%)Streptococcus species (17.0%)
Hernandez-Camarena (2015)MexicoMexico City2002–2011163833Staphylococcus epidermidis (25%)Pseudomonas aeruginosa (12%)Coagulase negative staphylococci (10%)
Sand (2015)USALos angeles2008–201247662Coagulase negative staphylococci (51.4%)Pseudomonas aeruginosa (15.3%)Staphylococcus aureus (12.8%)
Rossetto (2017)USAMiami1992–201510758Pseudomonas aeruginosa (42.1%)Strenotrophomonas maltophilia (17.5%)Serratia marcescens (8.8%)
Tam (2017)CanadaToronto2000–2015233049Coagulase negative staphylococci (37%)Staphylococcus aureus (15%)Streptococcus species (15%)
Jin (2017)USAHouston2011–20159662Pseudomonas aeruginosa (33.9%)Coagulase negative staphylococci (26.8%)Streptococcus pneumoniae (10.7%)
Peng (2018)USASan Francisco1996–2015220324Staphylococcus aureus (25.1%)Coagulase negative staphylococci (20.5%)Streptococcus viridans (13%)
Termote (2018)CanadaVancouver2006–201128175Coagulase negative staphylococci (25.6%)Streptococcus species (12.4%)Staphylococcus aureus (12.1%)

2.2. Positive Rate of Culture

A total of 38,931 samples scraping from the cornea of BK patients were reviewed in the study. Among them, 14,596 samples were culture positive and positive rate of culture was 47% (95%CI, 42–52%) based on the 38 studies (Figure 2). The highest positive rate was 83% and the lowest positive rate was 21%. Data of positive rate was available among 21 countries (35 cities) in 5 continents. The highest and the lowest positive rate analyzed by counties were from Korea and from Turkey (83% vs. 28%, Figure 3, Table S1). There were no significant differences of positive culture rate among different countries (p = 0.464). Grouped by continents, the highest positive rate was 59% (95%CI, 48–68%), found in 4 articles performed in Oceania and the lowest was 40% (95%CI, 32–49%), found in 14 articles performed in Asia. However, there were no significant differences of positive culture rate between continents (p = 0.211).
Figure 2

Analysis of positive rate of bacterial culture (38 studies).

Figure 3

Positive rate of bacterial culture from corneal lesions in different regions.

2.3. Distribution of Bacteria Isolated from Corneal Lesions

Within 14,596 samples reported from 38 studies, 15,350 bacterial strains isolated from corneas of BK cases were summarized (Table 2). Gram-positive cocci were the major type of bacteria (62%, 58–67%), followed by Gram-negative bacilli (30%, 26–33%), Gram-positive bacilli (5%, 4–7%), and Gram-negative cocci (5%, 4–7%). The five most common bacterial organism detected was Staphylococcus spp. (41.4%, 36.2–46.7%), Pseudomonas spp. (17.0%, 13.9–20.7%), Streptococcus spp. (13.1%, 10.9–15.7%), Corynebacterium spp. (6.6%, 5.3–8.3%) and Moraxella spp. (4.1%, 3.1–5.4%). Figure 4 presented the increasing trends of Gram-positive cocci and the decreasing trends of Gram-negative bacilli in 1996–2015. In 2000s, the proportion of Gram-positive cocci exceeded that of Gram-negative bacilli. The upward trend of Gram-positive cocci and the downward trend of Gram-negative bacilli were both significant (z = 1.71, p = 0.04; z = −1.88, p = 0.03). At the genus level, the percentage of Pseudomonas spp. declined from 39.9% (1990s) to 12.2% (2000s) and Staphylococcus spp. rose from 25.9% (1990s) to 39.5% (2000s) (Figure 4). The upward trend of Staphylococcus spp. was significant (z = 1.71, p = 0.04) and the downward trend of Pseudomonas spp. was not significant (z = −1.22, p = 0.22).
Table 2

Distribution of bacteria isolated from corneal lesions of bacterial keratitis.

OrganismIsolatesPercentage (%)95%CI (%)
Gram-positive cocci 8786 62.3 57.9~66.5
Staphylococcus 531141.436.2~46.7
Streptococcus 191313.110.9~15.7
Gemella 183.82.4~6.0
Micrococcus 412.51.8~3.3
Kocuria 121.60.9~2.8
Enterococcus 101.30.7~2.4
Aerococcus 70.80.3~1.6
Leuconostoc 60.80.4~1.7
Peptostreptococcus 20.70.2~2.9
Gram-negative bacilli 3776 29.6 26.0~33.5
Pseudomonas 233117.013.9~20.7
Moraxella 3114.13.1~5.4
Serratia 3733.42.7~4.2
Haemophilus 642.21.8~2.8
Proteus 542.11.1~4.0
Escherichia 382.01.5~2.7
Klebsiella 171.81.1~2.8
Achromobacter 11.90.0~12.2
Acinetobacter 261.81.3~2.7
Burkholderia 181.81.2~2.9
Enterobacter 131.20.7~2.0
Stenotrophomonas 111.10.6~2.0
Citrobacter 21.00.3~3.9
Morganella 50.90.4~2.0
Gram-positive bacilli 8715.23.9~6.8
Corynebacterium 2846.65.2~8.3
Nocardia 963.92.4~6.0
Cutibacterium 2433.31.7~6.0
Bacilli 1842.60.7~8.5
Sphingomonas 22.60.7~8.5
Brevibacterium 22.60.7~8.5
Clostridium 21.00.3~3.9
Mycobacterium 100.80.4~1.5
Aeromonas 30.80.3~2.1
Gram-negative cocci 265.23.9~6.8
Neisseria 50.80.3~1.9
not mentioned 189111.99.3~15.1
Figure 4

The changing trends of bacterial isolates from corneal lesions in 1990s–2020s.

2.4. Antibiotic Susceptibility of the Bacterial Strains Isolated from Corneal Lesions

All results of drug susceptibility tests of the strains were summarized in Figure 5. Most Gram-positive cocci were susceptible to aminoglycoside (86%, 3916 sensitive in 4527), following cephalosporin and fluoroquinolone, 79% (1997 sensitive in 2515) and 81% (3921 sensitive in 4831), separately. A resistance of macrolides was observed (57%, 212 sensitive in 375). As for Gram-negative bacilli, most isolates were susceptible to cephalosporin and fluoroquinolone (cephalosporin: 96%, 1269 sensitive in 1328; fluoroquinolone: 96%, 2519 sensitive in 2611), followed by aminoglycoside (92%, 2547 sensitive in 2783). Figure 6 shown the changing trends of susceptibility of pathogens to common drugs. In Gram-positive cocci, the susceptibility to common antibiotics such as cefazolin, gatifloxacin, moxifloxacin and ofloxacin showed a decreasing trend since 2010. For Gram-negative bacilli, a susceptibility over 90% was maintained in all recommended antibiotics [24] in recent years.
Figure 5

Results of drug susceptibility test of the strains isolated from corneal lesions.

Figure 6

The changing trends of drug susceptibility in 1990s–2020s.

3. Discussion

Bacterial keratitis is the second most common cause of legal blindness worldwide [25]. Although broad-spectrum antibiotics, such as levofloxacin, have always been used to control BK, more targeted treatment was required to improve the clinical outcomes [26]. However, the spectrum of pathogenic bacteria and their susceptibility to antibiotics varied with the different regions. Kaye et al. showed that these variations were related to the latitude and the degree of urbanization of the population studied [26]. Therefore, local epidemiology of bacterial spectrum and its resistance to antibiotics should be paid attention and is mandatory to know. In this study, 30-year changing trends of microbiological profile of BK were reviewed. From our results, the average rate of positive culture from the samples of BK was 47%. The large difference in positive culture rates (21~83%) between literatures may be related to the different indications of corneal scrapes in different medical institutions, the ability of microbiology laboratory, or to the fact that the study population had already received topical antibiotics treatment before corneal scraping. In this study, the common bacterial isolates were Staphylococcus spp., Pseudomonas spp., Streptococcus spp., Corynebacterium spp. and Moraxella spp., which was consistent with studies in the USA [27], UK and Canada. Although the number of Moraxella strains was 311, lower than that in Serratia strains (373), Moraxella spp. were isolated from 7121 samples (4.4%, 16 studies) and 373 Serratia spp. were isolated from 10,431 samples (3.6%, 27 studies). Thus, we concluded that Moraxella spp. were more common than Serratia spp. Pseudomonas spp. was demonstrated to be the most common pathogen in Singapore and Malaysia, which may result from a local high frequency of using contact lenses. Keya et al. found the percentage of Enterobacterales was 15.3%, higher than the percentage of Staphylococcus aureus and Pseudomonas aeruginosa. In addition, the upward trend of Gram-positive cocci and the downward trend of Gram-negative bacilli were observed, especially for the upward trend of Staphylococcus spp. and the downward trend of Pseudomonas spp. at the genus level. Similar trends were also presented in the studies from the UK [6] and Iran [23]. CoNS, one of the most common strains of Staphylococcus spp., was the major bacteria of normal skin, including eye lid. It would have more opportunity to contaminate the cornea; in addition, the conduction of corneal scraping was also easily susceptible to its contamination. The decreasing percentage of Pseudomonas spp. may be attributed to the wide application of some antibiotics, such as tobramycin and fluoroquinolones, and to the improvement in health conditions. Though several studies [4,5,6] reported a significant increase of Moraxella keratitis in UK for the last two decades, the trend was not shown in this worldwide study. Perhaps this trend was limited to specific regions. In Gram-positive cocci, most isolates were susceptible to aminoglycoside (86%, 3916 sensitive in 4527), and resistant to macrolides in more than half of drug susceptivity tests (57%, 212 sensitive in 375). In the other two classes of antibiotics commonly used in clinical practice against Gram-positive cocci, cephalosporin and fluoroquinolone, 79% (1997 sensitive in 2515) and 81% (3921 sensitive in 4831) isolates showed susceptivity. Since 2010, the susceptibility of Gram-positive cocci to common antibiotics such as cefazolin, gatifloxacin, moxifloxacin and ofloxacin has shown a decreasing trend. For Gram-negative bacilli, most isolates were susceptive to cephalosporin (96%, 1269/1328) and fluoroquinolones (96%, 2519/2611), followed by aminoglycoside (92%, 2547/2783). The trends of susceptibility seemed stable and maintained above 90%. Some studies had reported a group of Pseudomonas spp. with multiple drug resistance [28,29]. It is necessary to use targeted antibiotics in case of the development of resistant strains. The meta-analysis revealed the trend and distribution of bacterial keratitis pathogens and their drug resistance pattern guiding ophthalmologists to diagnosis and to choosing antibiotics based on their local data. Our study also possessed some limitations. Original studies often reported their results via time period (e.g., 2000–2005 CoNS 30%), not specific year (e.g., 2000 CoNS 30%), which affected the accuracy of our study. Differences between original studies, such as culture methods, participants who received topical antibiotics treatment before corneal scraping and experience of clinics would increase the difficulty of pathogen distribution analysis. Our study could still provide useful guidance for clinics. In conclusion, the worldwide average positive culture was 47% between 2000 to 2020. The percentage of Gram-positive cocci was increasing, and the percentage of Gram-negative bacilli was decreasing. The five most common bacterial organism were Staphylococcus spp., Pseudomonas spp., Streptococcus spp., Corynebacterium spp. and Moraxella spp. Increasing trends of Gram-positive cocci and the decreasing trends of Gram-negative bacilli were observed in 1996–2015. Most Gram-positive cocci were susceptive to aminoglycoside and were resistant to macrolides. Gram-negative bacilli were sensitive to cephalosporin, fluoroquinolone and aminoglycoside and maintained susceptibility above 90%. The decreasing trends of susceptibility were observed in Gram-positive cocci to most common antibiotics. Ophthalmologists should pay attention to the changing trends of pathogen distribution and their drug resistance patterns and modify the diagnosis and choose sensitive antibiotics based on the local data.

4. Materials and Methods

4.1. Databases and Search Strategy

Four databases, including Embase, Medline, Web of Science, and CINAHL, were searched, and publication date of articles were limited between January 2000 to December 2020. Main key words were “bacterial keratitis”, “culture results” and “drug resistance”. The whole search strategy was (“bacterial keratitis” OR “infectious keratitis” OR “microbial keratitis” OR “bacterial infections” OR “corneal ulcers” OR “bacterial infections of cornea”) AND (“organisms” OR “culture results” OR “isolates” OR “microbiology” OR “antibiotic susceptibility” OR “resistance pattern”). In addition, the document type was restricted to “article”, the language was restricted to “English”, and the subjects were restricted to “human”. More details of the search strategy could be found in Supplement Materials Table S1.

4.2. Literature Selection and Quality Assessment

The literature searched in the above databases was imported into the EndNote X 9 software library for merging and de-duplicating; then, the titles and abstracts were screened by two researchers (Z.Z., J.L.) according to the following inclusion criteria: (1) Purpose of the article should concentrate on reporting the distribution and resistance pattern of bacterial keratitis isolates; (2) Subjects of the literature must contain patients suspected of infective keratitis and confirmed by positive bacterial culture results; (3) Pathogens were isolating from corneal scrapes via culture and were identified at least at the genus level; (4) Drug susceptibility tests should be conducted for isolated strains via in vitro minimum inhibitory concentration testing (MIC) or the disk diffusion method. The homogeneity of our meta-analysis was controlled by exclusive criteria below: (1) Subjects with small sample size or specific risk factors; (2) Subjects already selected by authors would be excluded for positive rate analysis. (3) Multiple articles published using the same data would be deduplicated. After preliminary exclusion of unrelated references, we downloaded the full text of each citation; the literature quality was evaluated based on a methodological scoring system of “rate” [30]. The detailed quality criteria were as follows: (1) Whether there is a clear diagnostic basis for bacterial keratitis; (2) Whether the sample size (the number of bacterial culture specimens) is greater than 246 cases; (3) Whether there are clear criteria for positive bacterial culture; (4) Whether there are clear study parameters, such as positive rate or drug susceptibility results; (5) Whether the data is complete. Complete data should include the description of study populations, methods for the drug susceptibility test, and protocol for bacteria separating and identifying. Each criterion was given one score, and studies with a score of 4 or more were of high quality and included for analysis. All the steps of screening and quality assessment were carried out independently by two researchers (Z.W., X.X.). In case of disagreement over the inclusion of the literature, a third, more experienced researcher (Q.L.) would make the final decision.

4.3. Data Extraction

According to the purpose of this study, the data extraction scale of the literature was developed. For each included article, four aspects of information would be extracted. The first is the basic information of the literature and the institution of the author, including the publication year, time that the research was conducted, author, title, medical institution, etc. Next, the necessary data of positive rate of culture, bacterial strains distribution and drug susceptibility were extracted. The positive rate of culture was defined as the proportion of BK patients with positive culture results in all culture-treated patients suspected of infective keratitis. The parameter necessary for analyzing bacterial strain distribution contained the total number of strains isolated, number classified by Gram staining and number of strains as accurate as possible to species. Parameters related to drug susceptibility included the number of susceptible or resistant species performed on a certain species of bacterium to a certain drug. All above data were extracted into Microsoft Excel software.

4.4. Statistical Analysis

Data were analyzed with SPSS software (SPSS for windows, version 16.0, SPSS, Chicago, IL, USA). The meta-analysis was conducted using R program (V.4.0, R Foundation for Statistical Computing, Vienna, Austria) with meta package. All effect sizes were transformed into a single common metric, event rate with its 95% confidence interval, which indicated the number of participants in each sample endorsing bacterial keratitis. Either a random effects model or a fixed effects model was used to perform meta-analysis, which was determined by I2 statistic; I2 > 50% indicates a large heterogeneity among included studies and, correspondingly, a random effects model would be used; otherwise, a fixed effects model would be used.
Table A1

Databases searched in our study.

Database NameEndnote Importer OrderNumber of References before DeduplicationNumber of References after Deduplication (Removed)
Ovid Embase1829822
Ovid Medline(R)216971241
Web of Science321071515
CINAHL41010
TOTAL 3578
Table A2

Search information in Ovid Embase.

Database name Embase
Database platform Ovid
Date of database coverage 1974 to 6 December 2021
Date searched 12/07/2021
Searched by ZJ Zhang
Number of hits 829
Table A3

Search information in Ovid Medline(R).

Database name Medline(R)
Database platform Ovid
Date of database coverage 1946 to November Week 4 2021
Date searched 12/07/2021
Searched by ZJ Zhang
Number of hits 1697
Table A4

Search information in Web of Science.

Database name Web of Science Core
Database platform Web of Science
Date of database coverage 1985 to 2021
Date searched 12/07/2021
Searched by ZJ Zhang
Number of hits 2107
Table A5

Search information in EBSCO CLNAHL.

Database name CINAHL
Database platform EBSCO
Date of database coverage 1961 to present
Date searched 12/07/2021
Searched by ZJ Zhang
Number of hits 101
  63 in total

1.  Shifting trends in bacterial keratitis in Toronto: an 11-year review.

Authors:  Alejandro Lichtinger; Sonia N Yeung; Peter Kim; Maoz D Amiran; Alfonso Iovieno; Uri Elbaz; Judy Y F Ku; Rachel Wolff; David S Rootman; Allan R Slomovic
Journal:  Ophthalmology       Date:  2012-05-23       Impact factor: 12.079

2.  Paediatric infectious keratitis: a case series of 107 children presenting to a tertiary referral centre.

Authors:  Julia Dutra Rossetto; Kara M Cavuoto; Carla J Osigian; Ta Chen Peter Chang; Darlene Miller; Hilda Capo; Oriel Spierer
Journal:  Br J Ophthalmol       Date:  2017-03-15       Impact factor: 4.638

3.  An 11-year analysis of microbial keratitis in the South West of England using brain-heart infusion broth.

Authors:  Shokufeh Tavassoli; Gayathri Nayar; Kieren Darcy; Mariusz Grzeda; Jon Luck; O Martin Williams; Derek Tole
Journal:  Eye (Lond)       Date:  2019-05-09       Impact factor: 3.775

4.  Microbial keratitis in Hong Kong: relationship to climate, environment and contact-lens disinfection.

Authors:  E Houang; D Lam; D Fan; D Seal
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jul-Aug       Impact factor: 2.184

5.  Bacterial keratitis in Christchurch, New Zealand, 1997-2001.

Authors:  Reece C Hall; Malcolm J McKellar
Journal:  Clin Exp Ophthalmol       Date:  2004-10       Impact factor: 4.207

6.  Clinical and Microbiological Profile of Bacterial Microbial Keratitis in a Portuguese Tertiary Referral Center-Where Are We in 2015?

Authors:  Carla Sofia Ferreira; Luis Figueira; Nuno Moreira-Gonçalves; Raúl Moreira; Luis Torrão; Fernando Falcão-Reis
Journal:  Eye Contact Lens       Date:  2018-01       Impact factor: 2.018

7.  Profile of sight-threatening infectious keratitis: a prospective study.

Authors:  Ahmad M Otri; Usama Fares; Mouhamed A Al-Aqaba; Ammar Miri; Lana A Faraj; Dalia G Said; Senthil Maharajan; Harminder S Dua
Journal:  Acta Ophthalmol       Date:  2012-08-03       Impact factor: 3.761

8.  Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis.

Authors:  Stephen Kaye; Stephen Tuft; Timothy Neal; Derek Tole; John Leeming; Francisco Figueiredo; Malcolm Armstrong; Peter McDonnell; Andrew Tullo; Christopher Parry
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-13       Impact factor: 4.799

9.  Infectious Keratitis: Microbiological Review of 297 Cases.

Authors:  Daniel Tena; Natividad Rodríguez; Laura Toribio; Alejandro González-Praetorius
Journal:  Jpn J Infect Dis       Date:  2018-10-31       Impact factor: 1.362

10.  12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study.

Authors:  Darren Shu Jeng Ting; Charlotte Shan Ho; Jessica Cairns; Ahmad Elsahn; Mouhamed Al-Aqaba; Tim Boswell; Dalia G Said; Harminder Singh Dua
Journal:  Br J Ophthalmol       Date:  2020-06-24       Impact factor: 4.638

View more
  2 in total

Review 1.  Potential new fluoroquinolone treatments for suspected bacterial keratitis.

Authors:  Rose Herbert; Mary Caddick; Tobi Somerville; Keri McLean; Shakeel Herwitker; Timothy Neal; Gabriela Czanner; Stephen Tuft; Stephen B Kaye
Journal:  BMJ Open Ophthalmol       Date:  2022-07

Review 2.  Research Progress and Potential Applications of Spermidine in Ocular Diseases.

Authors:  Wentao Han; Haoyu Li; Baihua Chen
Journal:  Pharmaceutics       Date:  2022-07-19       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.